SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-044556
Filing Date
2023-12-12
Accepted
2023-12-12 16:20:20
Documents
15
Period of Report
2023-12-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37135
2 ex99-1.htm EX-99.1 9209
3 ex99-1_001.jpg GRAPHIC 48760
  Complete submission text file 0001493152-23-044556.txt   285562

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eltp-20231212.xsd EX-101.SCH 3024
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eltp-20231212_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eltp-20231212_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3127
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 231481485
SIC: 2834 Pharmaceutical Preparations